Karin K Shih1, Carla Hajj2, Marisa Kollmeier2, Melissa K Frey3, Yukio Sonoda4, Nadeem R Abu-Rustum4, Kaled M Alektiar5. 1. Gynecologic Oncology, Women's Comprehensive Health Center, Northwell Health Physician Partners, Manhasset, NY, USA. 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. New York University Langone Medical Center, New York, NY, USA. 4. Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA. 5. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: alektiak@mskcc.org.
Abstract
OBJECTIVE: The purpose was to determine the potential impact of IMRT on the rate of bowel obstruction (BO), in patients with gynecologic malignancies undergoing postoperative pelvic RT. METHODS: We performed a retrospective review of all patients with endometrial or cervical cancer who received postoperative pelvic RT at our institution from 2000 to 2012. Patients who received definitive or palliative RT, or those with BO due to disease progression, were excluded. Standard two-sided statistical tests were used to evaluate for associated risk factors. Kaplan-Meier, Log rank and Cox proportional hazards regression analysis tests were performed for actuarial analysis. RESULTS: A total of 224 patients were identified, 120 (54%) received postoperative pelvic IMRT and 104 (46%) 3-dimentional (3-D) RT. Median follow-up time was 67months. BO was grade 1 (asymptomatic) in 2/228 (0.9%), grade 2 (conservative management) in 4 (1.8%), and grade 3≥ in 4 (1.8%). Overall, the 5-year actuarial rate of BO was 4.8%. The 5-year rate of BO in the IMRT group was 0.9% compared to 9.3% for 3-D RT (p=0.006). Patients with BMI≥30kg/m(2) were less likely to develop BO (2.6% vs. 8.3; p=0.03). On multivariate analysis, only IMRT retained its significance as an independent predictor of less BO (p=0.022). CONCLUSIONS: The use of postoperative IMRT for cervical and endometrial cancer was associated with significant reduction in the rate of bowel obstruction. This difference maintained its statistical significance on multivariate analysis. Such finding if confirmed by others will help further solidify the benefit of IMRT in gynecologic cancers.
OBJECTIVE: The purpose was to determine the potential impact of IMRT on the rate of bowel obstruction (BO), in patients with gynecologic malignancies undergoing postoperative pelvic RT. METHODS: We performed a retrospective review of all patients with endometrial or cervical cancer who received postoperative pelvic RT at our institution from 2000 to 2012. Patients who received definitive or palliative RT, or those with BO due to disease progression, were excluded. Standard two-sided statistical tests were used to evaluate for associated risk factors. Kaplan-Meier, Log rank and Cox proportional hazards regression analysis tests were performed for actuarial analysis. RESULTS: A total of 224 patients were identified, 120 (54%) received postoperative pelvic IMRT and 104 (46%) 3-dimentional (3-D) RT. Median follow-up time was 67months. BO was grade 1 (asymptomatic) in 2/228 (0.9%), grade 2 (conservative management) in 4 (1.8%), and grade 3≥ in 4 (1.8%). Overall, the 5-year actuarial rate of BO was 4.8%. The 5-year rate of BO in the IMRT group was 0.9% compared to 9.3% for 3-D RT (p=0.006). Patients with BMI≥30kg/m(2) were less likely to develop BO (2.6% vs. 8.3; p=0.03). On multivariate analysis, only IMRT retained its significance as an independent predictor of less BO (p=0.022). CONCLUSIONS: The use of postoperative IMRT for cervical and endometrial cancer was associated with significant reduction in the rate of bowel obstruction. This difference maintained its statistical significance on multivariate analysis. Such finding if confirmed by others will help further solidify the benefit of IMRT in gynecologic cancers.
Authors: Petra Georg; Dietmar Georg; Martin Hillbrand; Christian Kirisits; Richard Pötter Journal: Radiother Oncol Date: 2006-06-12 Impact factor: 6.280
Authors: Nora T Kizer; Premal H Thaker; Feng Gao; Israel Zighelboim; Matthew A Powell; Janet S Rader; David G Mutch; Perry W Grigsby Journal: Cancer Date: 2010-10-13 Impact factor: 6.860
Authors: Vivian E von Gruenigen; Chunqiao Tian; Heidi Frasure; Steven Waggoner; Henry Keys; Richard R Barakat Journal: Cancer Date: 2006-12-15 Impact factor: 6.860
Authors: Siping He; Beant S Gill; Dwight E Heron; Joseph L Kelley; Paniti Sukumvanich; Alexander B Olawaiye; Robert P Edwards; John Comerci; Sushil Beriwal Journal: Pract Radiat Oncol Date: 2016-06-15
Authors: Michael R Folkert; Karin K Shih; Nadeem R Abu-Rustum; Elizabeth Jewell; Marisa A Kollmeier; Vicky Makker; Richard R Barakat; Kaled M Alektiar Journal: Gynecol Oncol Date: 2012-11-15 Impact factor: 5.482
Authors: Mohit Kasibhatla; Robert W Clough; Gustavo S Montana; James R Oleson; Kim Light; Beverley A Steffey; Ellen L Jones Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-20 Impact factor: 7.038
Authors: Karin K Shih; Sarah A Milgrom; Nadeem R Abu-Rustum; Marisa A Kollmeier; Ginger J Gardner; William P Tew; Richard R Barakat; Kaled M Alektiar Journal: Gynecol Oncol Date: 2012-11-20 Impact factor: 5.482
Authors: Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Gregory Spiegel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544
Authors: William Small; Walter R Bosch; Mathew M Harkenrider; Jonathan B Strauss; Nadeem Abu-Rustum; Kevin V Albuquerque; Sushil Beriwal; Carien L Creutzberg; Patricia J Eifel; Beth A Erickson; Anthony W Fyles; Courtney L Hentz; Anuja Jhingran; Ann H Klopp; Charles A Kunos; Loren K Mell; Lorraine Portelance; Melanie E Powell; Akila N Viswanathan; Joseph H Yacoub; Catheryn M Yashar; Kathryn A Winter; David K Gaffney Journal: Int J Radiat Oncol Biol Phys Date: 2020-09-06 Impact factor: 7.038
Authors: Junzo Chino; Christina M Annunziata; Sushil Beriwal; Lisa Bradfield; Beth A Erickson; Emma C Fields; KathrynJane Fitch; Matthew M Harkenrider; Christine H Holschneider; Mitchell Kamrava; Eric Leung; Lilie L Lin; Jyoti S Mayadev; Marc Morcos; Chika Nwachukwu; Daniel Petereit; Akila N Viswanathan Journal: Pract Radiat Oncol Date: 2020-05-18